Musculoskeletal manifestations and autoantibodies in children and adolescents with leprosy

Objective:To evaluate musculoskeletal involvement and autoantibodies in pediatric leprosy patients.Methods:50 leprosy patients and 47 healthy children and adolescents were assessed according to musculoskeletal manifestations (arthralgia, arthritis, and myalgia), musculoskeletal pain syndromes (juvenile fibromyalgia, benign joint hypermobility syndrome, myofascial syndrome, and tendinitis), and a panel of autoantibodies and cryoglobulins. Health assessment scores and treatment were performed in leprosy patients.Results:At least one musculoskeletal manifestation was observed in 14% of leprosy patients and in none of the controls. Five leprosy patients had asymmetric polyarthritis of small hands joints. Nerve function impairment was observed in 22% of leprosy patients, type 1 leprosy reaction in 18%, and silent neuropathy in 16%. None of the patients and controls presented musculoskeletal pain syndromes, and the frequencies of all antibodies and cyoglobulins were similar in both groups (p > 0.05). Further analysis of leprosy patients demonstrated that the frequencies of nerve function impairment, type 1 leprosy reaction, and silent neuropathy were significantly observed in patients with versus without musculoskeletal manifestations (p = 0.0036, p = 0.0001, and p = 0.309, respectively), as well as multibacillary subtypes in leprosy (86% vs. 42%, p = 0.045). The median of physicians' visual analog scale (VAS), patients' VAS, pain VAS, and Childhood Health Assessment Questionnaire (CHAQ) were significantly higher in leprosy patients with musculoskeletal manifestations (p = 0.0001, p = 0.002, p = 0002, and p = 0.001, respectively).Conclusions:This was the first study to identify musculoskeletal manifestations associated with nerve dysfunction in pediatric leprosy patients. Hansen's disease should be included in the differential diagnosis of asymmetric arthritis, especially in endemic regions.

Saved in:
Bibliographic Details
Main Authors: Neder,Luciana, Rondon,Daniel A., Cury,Silvana S., Silva,Clovis A. da
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Pediatria 2014
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572014000500457
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0021-75572014000500457
record_format ojs
spelling oai:scielo:S0021-755720140005004572015-08-28Musculoskeletal manifestations and autoantibodies in children and adolescents with leprosyNeder,LucianaRondon,Daniel A.Cury,Silvana S.Silva,Clovis A. da Leprosy Arthritis Arthralgia Neuropathy Autoantibodies Objective:To evaluate musculoskeletal involvement and autoantibodies in pediatric leprosy patients.Methods:50 leprosy patients and 47 healthy children and adolescents were assessed according to musculoskeletal manifestations (arthralgia, arthritis, and myalgia), musculoskeletal pain syndromes (juvenile fibromyalgia, benign joint hypermobility syndrome, myofascial syndrome, and tendinitis), and a panel of autoantibodies and cryoglobulins. Health assessment scores and treatment were performed in leprosy patients.Results:At least one musculoskeletal manifestation was observed in 14% of leprosy patients and in none of the controls. Five leprosy patients had asymmetric polyarthritis of small hands joints. Nerve function impairment was observed in 22% of leprosy patients, type 1 leprosy reaction in 18%, and silent neuropathy in 16%. None of the patients and controls presented musculoskeletal pain syndromes, and the frequencies of all antibodies and cyoglobulins were similar in both groups (p > 0.05). Further analysis of leprosy patients demonstrated that the frequencies of nerve function impairment, type 1 leprosy reaction, and silent neuropathy were significantly observed in patients with versus without musculoskeletal manifestations (p = 0.0036, p = 0.0001, and p = 0.309, respectively), as well as multibacillary subtypes in leprosy (86% vs. 42%, p = 0.045). The median of physicians' visual analog scale (VAS), patients' VAS, pain VAS, and Childhood Health Assessment Questionnaire (CHAQ) were significantly higher in leprosy patients with musculoskeletal manifestations (p = 0.0001, p = 0.002, p = 0002, and p = 0.001, respectively).Conclusions:This was the first study to identify musculoskeletal manifestations associated with nerve dysfunction in pediatric leprosy patients. Hansen's disease should be included in the differential diagnosis of asymmetric arthritis, especially in endemic regions.info:eu-repo/semantics/openAccessSociedade Brasileira de PediatriaJornal de Pediatria v.90 n.5 20142014-10-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572014000500457en10.1016/j.jped.2014.01.007
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Neder,Luciana
Rondon,Daniel A.
Cury,Silvana S.
Silva,Clovis A. da
spellingShingle Neder,Luciana
Rondon,Daniel A.
Cury,Silvana S.
Silva,Clovis A. da
Musculoskeletal manifestations and autoantibodies in children and adolescents with leprosy
author_facet Neder,Luciana
Rondon,Daniel A.
Cury,Silvana S.
Silva,Clovis A. da
author_sort Neder,Luciana
title Musculoskeletal manifestations and autoantibodies in children and adolescents with leprosy
title_short Musculoskeletal manifestations and autoantibodies in children and adolescents with leprosy
title_full Musculoskeletal manifestations and autoantibodies in children and adolescents with leprosy
title_fullStr Musculoskeletal manifestations and autoantibodies in children and adolescents with leprosy
title_full_unstemmed Musculoskeletal manifestations and autoantibodies in children and adolescents with leprosy
title_sort musculoskeletal manifestations and autoantibodies in children and adolescents with leprosy
description Objective:To evaluate musculoskeletal involvement and autoantibodies in pediatric leprosy patients.Methods:50 leprosy patients and 47 healthy children and adolescents were assessed according to musculoskeletal manifestations (arthralgia, arthritis, and myalgia), musculoskeletal pain syndromes (juvenile fibromyalgia, benign joint hypermobility syndrome, myofascial syndrome, and tendinitis), and a panel of autoantibodies and cryoglobulins. Health assessment scores and treatment were performed in leprosy patients.Results:At least one musculoskeletal manifestation was observed in 14% of leprosy patients and in none of the controls. Five leprosy patients had asymmetric polyarthritis of small hands joints. Nerve function impairment was observed in 22% of leprosy patients, type 1 leprosy reaction in 18%, and silent neuropathy in 16%. None of the patients and controls presented musculoskeletal pain syndromes, and the frequencies of all antibodies and cyoglobulins were similar in both groups (p > 0.05). Further analysis of leprosy patients demonstrated that the frequencies of nerve function impairment, type 1 leprosy reaction, and silent neuropathy were significantly observed in patients with versus without musculoskeletal manifestations (p = 0.0036, p = 0.0001, and p = 0.309, respectively), as well as multibacillary subtypes in leprosy (86% vs. 42%, p = 0.045). The median of physicians' visual analog scale (VAS), patients' VAS, pain VAS, and Childhood Health Assessment Questionnaire (CHAQ) were significantly higher in leprosy patients with musculoskeletal manifestations (p = 0.0001, p = 0.002, p = 0002, and p = 0.001, respectively).Conclusions:This was the first study to identify musculoskeletal manifestations associated with nerve dysfunction in pediatric leprosy patients. Hansen's disease should be included in the differential diagnosis of asymmetric arthritis, especially in endemic regions.
publisher Sociedade Brasileira de Pediatria
publishDate 2014
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572014000500457
work_keys_str_mv AT nederluciana musculoskeletalmanifestationsandautoantibodiesinchildrenandadolescentswithleprosy
AT rondondaniela musculoskeletalmanifestationsandautoantibodiesinchildrenandadolescentswithleprosy
AT curysilvanas musculoskeletalmanifestationsandautoantibodiesinchildrenandadolescentswithleprosy
AT silvaclovisada musculoskeletalmanifestationsandautoantibodiesinchildrenandadolescentswithleprosy
_version_ 1756375898533134336